Korro Bio
Develops RNA editing medicines for rare and prevalent diseases.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
biotechpharmaceuticals
Company facts
- Founded
- 2018
- Employees
- 87
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: KRRO
Open positions
5 jobs
2 views 3 weeks ago
Associate Medical Director / Medical Director
HybridNorth America
United States
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of…
Business Development GCP